Get started
Author

Feilong Qi

Observed name: Fei-long Qi
ORCID: 0009-0003-8217-5997
Observed ORCID: 0009-0003-8217-5997
OpenAlex ID: A5104096823
The dynamic role of platelets in cancer progression and their therapeutic implications
2023 · Suping Li, Zefang Lu, et al. · Nature reviews. Cancer · 218
Platelet-Membrane-Coated Nanoparticles Enable Vascular Disrupting Agent Combining Anti-Angiogenic Drug for Improved Tumor Vessel Impairment
2021 · Bozhao Li, Tianjiao Chu, et al. · Nano Letters · 157
Diosgenin promotes antitumor immunity and PD-1 antibody efficacy against melanoma by regulating intestinal microbiota
2018 · Mengxue Dong, Zhefeng Meng, et al. · Cell Death and Disease · 114
PDF
Reversal of the immunosuppressive tumor microenvironment by nanoparticle-based activation of immune-associated cells
2020 · Fei-long Qi, Mei-fang Wang, et al. · Acta Pharmacologica Sinica · 45
PDF
Reducing Postoperative Recurrence of Early‐Stage Hepatocellular Carcinoma by a Wound‐Targeted Nanodrug
2022 · Bozhao li, Xiuping Zhang, et al. · Advanced Science · 41
PDF
An Activatable Host–Guest Conjugate as a Nanocarrier for Effective Drug Release through Self-Inclusion
2021 · Han Wu, Hua Wang, et al. · ACS Applied Materials & Interfaces · 33
The Combination of Sinusoidal Perfusion Enhancement and Apoptosis Inhibition by Riociguat Plus a Galactose-PEGylated Bilirubin Multiplexing Nanomedicine Ameliorates Liver Fibrosis Progression
2023 · Fenfen Li, Zhaoxia Cheng, et al. · Nano Letters · 23
Molecularly engineered truncated tissue factor with therapeutic aptamers for tumor-targeted delivery and vascular infarction
2020 · Bozhao Li, Jingyan Wei, et al. · Acta Pharmaceutica Sinica B · 23
PDF
A Cleavable Self-Inclusion Conjugate with Enhanced Biocompatibility and Antitumor Bioactivity
2022 · Han Wu, Tian Xia, et al. · CCS Chemistry · 21
Nanoparticle-Based Combination Therapy Enhances Fulvestrant Efficacy and Overcomes Tumor Resistance in ER-Positive Breast Cancer
2023 · Bozhao Li, Feilong Qi, et al. · Cancer Research · 19
S-ethyl ethanethiosulfinate, a derivative of allicin, induces metacaspase-dependent apoptosis through ROS generation in Penicillium chrysogenum
2019 · Feilong Qi, Chen Zhang, et al. · Bioscience Reports · 14
PDF
Colonic electrical stimulation promotes colonic motility through regeneration of myenteric plexus neurons in slow transit constipation beagles
2019 · Yongbin Wang, Qian Wang, et al. · Bioscience Reports · 14
Monitoring circulating platelet activity to predict cancer-associated thrombosis
2023 · Bozhao Li, Zefang Lu, et al. · Cell Reports Methods · 12
Personalized 3D Vaccine Integrates Immunotherapy and Antiangiogenic Therapy to Prevent Oral Squamous Cell Carcinoma Recurrence
2025 · Jinna Ren, Tianjiao Chu, et al. · Advanced Materials · 10
Targeted Inhibition of Lymphovascular Invasion Formation with CREKA Peptide-Modified Silicasomes to Boost Chemotherapy in Bladder Cancer
2024 · Zhouliang Wu, Bozhao Li, et al. · Nano Letters · 9
Nanoparticle-based combination of LMWH and doxorubicin for the efficient treatment of hepatocellular carcinoma with portal vein tumor thrombus
2023 · Xiu-Ping Zhang, Bozhao Li, et al. · Nano Today · 6
Selective apoptosis of tumor-associated platelets boosts the anti-metastatic potency of PD-1 blockade therapy
2025 · Suying Wu, Zhouliang Wu, et al. · Cell Reports Medicine · 4
Identification of protein kinase C beta as a therapeutic target for neuroendocrine prostate cancer and development of a nanoparticle-based therapeutic strategy
2022 · Yunkai Qie, Zhaoxia Cheng, et al. · Nano Today · 3
Supplementary Data from Nanoparticle-Based Combination Therapy Enhances Fulvestrant Efficacy and Overcomes Tumor Resistance in ER-Positive Breast Cancer
2025 · Bozhao Li, Feilong Qi, et al.
Supplementary Data from Nanoparticle-based combination therapy enhances fulvestrant efficacy and overcomes tumor resistance in ER-positive breast cancer
2024 · Bozhao Li, Feilong Qi, et al.
Supplementary Data from Nanoparticle-based combination therapy enhances fulvestrant efficacy and overcomes tumor resistance in ER-positive breast cancer
2024 · Bozhao Li, Feilong Qi, et al.
Data from Nanoparticle-based combination therapy enhances fulvestrant efficacy and overcomes tumor resistance in ER-positive breast cancer
2024 · Bozhao Li, Feilong Qi, et al.
Data from Nanoparticle-Based Combination Therapy Enhances Fulvestrant Efficacy and Overcomes Tumor Resistance in ER-Positive Breast Cancer
2023 · Bozhao Li, Feilong Qi, et al.
Supplementary Data from Nanoparticle-Based Combination Therapy Enhances Fulvestrant Efficacy and Overcomes Tumor Resistance in ER-Positive Breast Cancer
2023 · Bozhao Li, Feilong Qi, et al.
Data from Nanoparticle-Based Combination Therapy Enhances Fulvestrant Efficacy and Overcomes Tumor Resistance in ER-Positive Breast Cancer
2023 · Bozhao Li, Feilong Qi, et al.
Works count: 26
Citation count: 766
H-index: 12
I10-index: 14
Year
Topic
Type